EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Untargeted Multiomics Approach Coupling Lipidomics and Metabolomics Profiling Reveals New Insights in Diabetic Retinopathy

Patricia Ancel, Jean Charles Martin iD, Elisa Doukbi, Marie Houssays, Pierre Gascon iD, Maud Righini, Frédéric Matonti iD, Ljubica Svilar iD, Marie Valmori, Catherine Tardivel, Nicolas Venteclef, Jean Baptiste Julla iD und 4 weitere

International Journal of Molecular Sciences · 27.07.2023 · 24 (15) · 12053

DOI: 10.3390/ijms241512053 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.07.2023. Verfasst von Patricia Ancel und 15 weiteren Autor:innen. Beteiligte Einrichtung: Aix-Marseille University, INSERM, INRAE, C2VN, 13005 Marseille, France. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Société Francophone du Diabète, GIRCI méditerrannée, GIRCI Mediterranée.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic retinopathy (DR) is a microvascular complication of diabetes mellitus (DM) which is the main cause of vision loss in the working-age population. Currently known risk factors such as age, disease duration, and hemoglobin A1c lack sufficient efficiency to distinguish patients with early stages of DR. A total of 194 plasma samples were collected from patients with type 2 DM and DR (moderate to proliferative (PDR) or control (no or mild DR) matched for age, gender, diabetes duration, HbA1c, and hypertension. Untargeted lipidomic and metabolomic approaches were performed. Partial-least square methods were used to analyze the datasets. Levels of 69 metabolites and 85 lipid species were found to be significantly different in the plasma of DR patients versus controls. Metabolite set enrichment analysis indicated that pathways such as metabolism of branched-chain amino acids (methylglutaryl carnitine p = 0.004), the kynurenine pathway (tryptophan p < 0.001), and microbiota metabolism (p-Cresol sulfate p = 0.004) were among the most enriched deregulated pathways in the DR group. Moreover, Glucose-6-phosphate (p = 0.001) and N-methyl-glutamate (p < 0.001) were upregulated in DR. Subgroup analyses identified a specific signature associated with PDR, macular oedema, and DR associated with chronic kidney disease. Phosphatidylcholines (PCs) were dysregulated, with an increase of alkyl-PCs (PC O-42:5 p < 0.001) in DR, while non-ether PCs (PC 14:0–16:1, p < 0.001; PC 18:2–14:0, p < 0.001) were decreased in the DR group. Through an unbiased multiomics approach, we identified metabolites and lipid species that interestingly discriminate patients with or without DR. These features could be a research basis to identify new potential plasma biomarkers to promote 3P medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic RetinopathyDiabetes Mellitus, Type 2HumansLipidomicsMultiomicsMetabolomicsLipids

Stichwörter der Autor:innen

diabetic retinopathylipidomicsmetabolomics

Substanzen

Lipids

Autor:innen und Institutionen

  • Aix-Marseille University, INSERM, INRAE, C2VN, 13005 Marseille, France.
  • Aix-Marseille University, INSERM, INRAE, C2VN, BIOMET Aix-Marseille Technology Platform, 13005 Marseille, France.
  • Medical Evaluation Department, Assistance-Publique Hôpitaux de Marseille, CIC-CPCET, 13005 Marseille, France.
  • Department of Ophthalmology, Assistance-Publique Hôpitaux de Marseille, 13005 Marseille, France.
  • Centre Monticelli Paradis, 433 bis rue Paradis, 13008 Marseille, France.
  • Groupe Almaviva Santé, Clinique Juge, 116 rue Jean Mermoz, 13008 Marseille, France.

ORCID-Profile: Jean Charles Martin, Pierre Gascon, Frédéric Matonti, Ljubica Svilar, Jean Baptiste Julla, Jean François Gautier, Noémie Resseguier, Bénédicte Gaborit

Förderung

  • Société Francophone du Diabète
  • GIRCI méditerrannée
  • GIRCI Mediterranée

Zitieren

APA

Ancel, P., Martin, J. C., Doukbi, E., Houssays, M., Gascon, P., Righini, M., Matonti, F., Svilar, L., Valmori, M., Tardivel, C., Venteclef, N., Julla, J. B., Gautier, J. F., Resseguier, N., Dutour, A., & Gaborit, B. (2023). Untargeted Multiomics Approach Coupling Lipidomics and Metabolomics Profiling Reveals New Insights in Diabetic Retinopathy. International Journal of Molecular Sciences, 24(15), 12053. https://doi.org/10.3390/ijms241512053

Vancouver

Ancel P, Martin JC, Doukbi E, Houssays M, Gascon P, Righini M, et al. Untargeted Multiomics Approach Coupling Lipidomics and Metabolomics Profiling Reveals New Insights in Diabetic Retinopathy. International Journal of Molecular Sciences. 2023;24(15):12053. doi:10.3390/ijms241512053

BibTeX
@article{Ancel2023,
  author = {Ancel, Patricia and Martin, Jean Charles and Doukbi, Elisa and Houssays, Marie and Gascon, Pierre and Righini, Maud and Matonti, Frédéric and Svilar, Ljubica and Valmori, Marie and Tardivel, Catherine and Venteclef, Nicolas and Julla, Jean Baptiste and Gautier, Jean François and Resseguier, Noémie and Dutour, Anne and Gaborit, Bénédicte},
  title = {Untargeted Multiomics Approach Coupling Lipidomics and Metabolomics Profiling Reveals New Insights in Diabetic Retinopathy},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {15},
  pages = {12053},
  doi = {10.3390/ijms241512053}
}
Kostenlos starten →